China Active Pharmaceutical Ingredients (API) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The China Active Pharmaceutical Ingredients (API) Market is Segmented by Business Mode (Captive API and Merchant API), Synthesis Type (Synthetic and Biotech), Drug Type (Generic and Branded), and Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other Applications). The report offers the value (in USD billion) for the above segments.

China Active Pharmaceutical Ingredients (API) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

China Active Pharmaceutical Ingredients (API) Industry Overview

The Chinese Active Pharmaceutical Ingredients market is relatively fragmented. The API market has several manufacturers focusing on expanding their footprints by adopting various business strategies, such as collaborations, facility expansion, and drug approvals. Some of the companies in the market are WuXi AppTec (WuXi STA), Asymchem Laboratories, Reyoung Pharmaceutical, Zhejiang NHU Co., Ltd, and Shijiazhuang and Pharmaceutical Group Co., Ltd, among others.

China Active Pharmaceutical Ingredients (API) Market Leaders

  1. WuXi AppTec (WuXi STA)

  2. Asymchem Laboratories

  3. Reyoung Pharmaceutical

  4. Zhejiang NHU Co., Ltd.

  5. CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd)

  6. *Disclaimer: Major Players sorted in no particular order
China Active Pharmaceutical Ingredients Market - cl.png

China Active Pharmaceutical Ingredients (API) Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?